Article ID Journal Published Year Pages File Type
5605055 International Journal of Cardiology 2017 29 Pages PDF
Abstract
This meta-analysis provides the evidence that add-on use of spironolactone in patients with resistant hypertension is effective in lowering SBP and DBP, suggesting an add-on use of spironolactone as fourth line therapy in patients with resistant hypertension.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
A meta-analysis of add-on use of spironolactone in patients with resistant hypertension
Authors
, , , ,